NCT05391854

Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects

Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects: a 12-week Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 128 (actual)
• Sponsor: Ingredia S.A. · Industry
• Sex: All
• Age: 25 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The goal is to assess the long-term effect of Pep2Dia® compared to placebo intake on blood glucose homeostasis. Respective improvements will be assessed by changes in glycated haemoglobin (HbA1c) before and after the 12-weeks intervention.

Conditions

• Prediabetic State

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Pep2dia	700 mg Pep2Dia® 15 min prior to breakfast and 700 mg Pep2Dia® 15 min prior to dinner
DIETARY_SUPPLEMENT	Placebo	700 mg placebo 15 min prior to breakfast and 700 mg placebo 15 min prior to dinner

Timeline

• Start date: 2022-06-21
• Primary completion: 2023-05-05
• Completion: 2023-06-20
• First posted: 2022-05-26
• Last updated: 2023-06-28

Locations

1 site across 1 country: Germany